Trinity Biotech (TRIB) was upgraded by
Weiss Ratings from "sell (e+)" to "sell (d-)".
Trinity Biotech (TRIB) had its "sell (d-)" rating reaffirmed by
Weiss Ratings.
Trinity Biotech Announces Successful Clinical Results for Its Enhanced EpiCapture™ Prostate Cancer Test [Yahoo! Finance]
Trinity Biotech Announces Collaboration with University at Buffalo to Commercialize Novel Biomarkers for Sjögren's Syndrome [Yahoo! Finance]
Trinity Biotech Announces Collaboration with University at Buffalo to Commercialize Novel Biomarkers for Sjögren’s Syndrome